Dear Division 28 Colleagues,
The Agency for Healthcare Research and Quality (AHRQ) posted a draft report on Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the Evidence Base for the PTSD Trials Standardized Data Repository. The draft report is available for review and public comment until March 28, 2023. We encourage you to consider submitting comments directly to AHRQ!
https://effectivehealthcare.ahrq.gov/products/ptsd-pharm-nonpharm-treatment-update-draft-report
Our office plans to review and submit comments as well and you are welcome to share your comments with us if you wish. If you would like to share your comments with our office, please email them to jmarzalik@apa.org by the end of the day Monday, March 27.
For any questions, please contact Dr. Raquel Halfond, Senior Director, Evidence-Based Practice and Health Equity, at rhalfond@apa.org.
Thank you,
Jacob S. Marzalik, MA (he/him/his)
Project Manager, Clinical Practice Guidelines
Practice Transformation and Quality, Practice Directorate
American Psychological Association
750 First Street NE, Washington DC 20002-4242
202-336-5872
All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.
No comments:
Post a Comment